US Patent Issued to The Regents of the University of California on Oct. 28 for "Human vaccine compositions and methods for treating leukemia" (California Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,763, issued on Oct. 28, was assigned to The Regents of the University of California (Oakland, Calif.).

"Human vaccine compositions and methods for treating leukemia" was invented by Karin Gaensler (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, inter alia, nucleic acids including coding sequences for human CD80, IL-15, IL-15RAlpha polypeptides, wherein the coding sequence for hCD80 is operably positioned upstream to the coding sequences for hIL-15 and hIL-15RAlpha. The disclosure also provides recombinant cells, cell cultures, pharmaceutical compositions, and whole-cell vaccines containing the recombinant cells discl...